50th Annual scientific sessions of the American college of cardiology.
SoRelle
R
R
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000628:therapy; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use; D015316:Genetic Therapy; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D011412:Propanolamines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D011725:Pyridines; D013777:Tetrazoles; D000077261:Carvedilol; D016222:Fibroblast Growth Factor 2; C120582:tezosentan